Outcomes of the Medacta shoulder implant system in people with shoulder joint problems
Follows people who received the Medacta shoulder implant for shoulder arthritis or fracture.
Plain-language title generated from the registry record
Registry title: Clinical and Radiological Outcomes of Medacta Shoulder System FR
Key facts
- Where
- Annecy, FranceSee the site
Where in France
- Clinique Générale AnnecyAnnecy, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medacta International SA
- Trial code
- NCT05926622
- Record updated
- 29 September 2025
- Original description
This is a post-marketing surveillance on Medacta Shoulder SystemRead full original descriptionShow less
Clinical and Radiological Outcomes of Medacta Shoulder System
This is a post-marketing surveillance on Medacta Shoulder System
Inclusion: Patients older than 18 years; Patient with one of the following diagnosis:; Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty.
Exclusion: Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery); Patients with malignant diseases (at the time of surgery); Patients with proven or suspect infections (at the time of surgery); Patients with known incompatibility or allergy to products materials (at the time of surgery).